NRXP Latest Quarter’s Earnings
Announce Date8/14/2026
EPS Actual (USD)-0.44
Revenue Actual (USD)1.10M
NRX Pharmaceuticals Inc Earnings Dates & Reports
This page offers detailed NRX Pharmaceuticals Inc earnings data including the latest NRX Pharmaceuticals Inc earnings report, the upcoming NRX Pharmaceuticals Inc earnings date, historical data and NRX Pharmaceuticals Inc earnings call news.
NRXP Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
NRXP FY2025 Earnings
EPS (YoY)-1.3443.34%
Revenue (YoY)1.23M--
NRX Pharmaceuticals Inc (NRXP) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/14/2026 | 06/2026 | -0.44/0.06 | 1.10M/16.56M | -785.61% | -93.35% |
| 5/15/2026 | 03/2026 | -0.04/0.29 | 1.07M/12.25M | -115.39% | -91.28% |
| 3/25/2026 | 12/2025 | 0.01/-0.00 | 983.00K/7.53M | 597.20% | -86.94% |
| 11/14/2025 | 09/2025 | -0.26/-0.09 | 242.00K/6.83M | -211.69% | -96.45% |
| 8/18/2025 | 06/2025 | -0.98/-0.20 | --/1.50M | -382.13% | -- |
| 5/15/2025 | 03/2025 | -0.34/-0.30 | --/1.14M | -11.96% | -- |
| 3/14/2025 | 12/2024 | -0.74/-0.32 | --/0.00 | -133.99% | -- |
| 11/14/2024 | 09/2024 | -0.15/-0.64 | --/0.00 | 76.89% | -- |
NRX Pharmaceuticals Inc Latest Earnings Call Transcripts
NRx Pharmaceuticals (NRXP) Q2 2026 Earnings Call: ANDA Progress and $26.7M Cash
NRx Pharmaceuticals’ Q2 2026 earnings call covered $26.7 million in cash, KETAFREE FDA progress, the SPARC-TMS trial and GeNeuro’s ALS program.